Factors Contributing to Increased Platelet Reactivity in People With Diabetes
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
eople with diabetes, particularly those with type 2 diabetes, exhibit increased platelet reactivity.Hyperglycemia contributes to greater platelet reactivity through direct effects and by promoting glycation of platelet proteins.Hypertriglyceridemia increases platelet reactivity.Both insulin resistance and insulin deficiency increase platelet reactivity.Insulin antagonizes activation of platelets.Thus, relative or absolute deficiency of insulin would be expected to increase platelet reactivity.Diabetes is associated with oxidative stress and inflammation.Resultant endothelial dysfunction promotes activation of platelets by decreasing production of nitric oxide (NO) that attenuates platelet reactivity.Oxidative stress accentuates this effect by attenuating activity of NO and promoting platelet activation.Inflammation and platelet activation are reciprocally related.Inflammation promotes platelet activation that, in turn, promotes inflammation.Accordingly, improved metabolic control achieved with regimens that improve insulin sensitivity and preserve pancreatic -cell function is likely to decrease platelet reactivity and enhance effects of antiplatelet agents.Platelets from subjects with diabetes exhibit increased reactivity (i.e., increased propensity to activate in response to a stimulus) (1).This review highlights factors that contribute to increased platelet reactivity.Type 2 diabetes is more prevalent than type 1 diabetes and is associated with a substantially increased risk of macrovascular complications.Accordingly, this review focuses on platelet reactivity in subjects with type 2 diabetes.Key aspects of type 2 diabetes are insulin resistance, metabolic abnormalities including hyperglycemia, and systemic abnormalities including oxidative stress and inflammation.The influence of each of these abnormalities on platelet function is addressed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evidence for abnormal platelet glycoprotein expression in diabetes mellitus
TSCHOEPE, D., ROESEN, P., KAUFMANN, L., SCHAUSEIL, S., KEHREL, B., OSTERMANN, H., & GRIES, F. A. (1990) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1990.tb02264.x · Cited by 217
Keating, F. K., Sobel, B. E., & Schneider, D. J. (2003) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.08.033 · Cited by 156 · cited 1×
“Osmotic effect of glucose is a second mechanism by which hyperglycemia can increase platelet reactivity (5).”
BackgroundSelf-citation
Cited by
Yahagi, K., Kolodgie, F. D., Lutter, C., Mori, H., Romero, M. E., Finn, A. V., & Virmani, R. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.306256 · Cited by 573
Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome
Ferreiro, J. L., & Angiolillo, D. J. (2011) · Circulation · doi:10.1161/circulationaha.109.913376 · Cited by 333
Role of Platelet Mitochondria: Life in a Nucleus-Free Zone
Melchinger, H., Jain, K., Tyagi, T., & Hwa, J. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00153 · Cited by 208
Non-genomic effects of nuclear receptors: insights from the anucleate platelet
Unsworth, A. J., Flora, G. D., & Gibbins, J. M. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy044 · Cited by 54
“Platelets are known to act as direct contributors towards the progression of CVDs such as atherosclerosis, 86 and their activity becomes considerably enhanced in cases of hyperlipidaemia, 87 obesity, 88 diabetes mellitus, 89 or hypertension.”
Metadata
- Authors
- Schneider, D. J.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-04-01
- Volume
- 32
- Issue
- 4
- Pages
- 525-527
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2108112200
- Cited by
- 223
- References
- 2
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.